Product Information
ETODOLAC ER 400 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7206 per EA under NDC 00093112201. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093112201
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETODOLACApproval Type
Generic (ANDA)
FDA Application
ANDA075665FDA Approved
7/31/2000
TE Code
AB
On Market Since
2/9/2001
Pharmacological Classes
Price Statistics
The NADAC for ETODOLAC ER 400 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 57.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7206 per EA |
|---|---|
| All-time high | $2.3164 (May 14, 2014) |
| All-time low | $0.7206 (Aug 19, 2026) |
| 52-week high | $1.1052 |
| 52-week low | $0.7206 |
| Median price | $1.8607 |
| Average price | $1.6746 |
| Largest weekly change | +52.0% (Jun 21, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ETODOLAC ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC ER 400 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7206 per EA (NDC 00093112201), effective Aug 19, 2026.
How has the price of ETODOLAC ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETODOLAC ER 400 MG TABLET has declined 57.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ETODOLAC ER 400 MG TABLET?
Since Nov 28, 2013, the NADAC for ETODOLAC ER 400 MG TABLET has ranged from a low of $0.7206 (Aug 19, 2026) to a high of $2.3164 (May 14, 2014), with a median of $1.8607 per EA.
Are there cheaper alternatives to ETODOLAC ER 400 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETODOLAC 400 MG TABLET, is $0.2518 per EA — about 65% below ETODOLAC ER 400 MG TABLET.
Who manufactures ETODOLAC ER 400 MG TABLET?
ETODOLAC ER 400 MG TABLET (NDC 00093112201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.